APOA1 and type 2 diabetes mellitus: found that infusing recombinant HDL-C prepared with apoA-I and soybean phosphatidylcholine in patients with type 2 diabetes enhanced insulin secretion from pancreatic β-cells and increased glucose uptake in skeletal muscle, resulting in lower blood glucose levels (35).